by CytoPrevent | Oct 22, 2015 | Studies
Chun-Yip Hon, Kay Teschke, Hui Shen, Paul A. Demers, Scott Venners Abstract: Purpose: The purpose of this study was to quantify the urine concentration of non-metabolized cyclophosphamide (CP), a commonly administered antineoplastic drug, among potentially exposed...
by CytoPrevent | Oct 13, 2015 | Studies
Seth Eisenberg Abstract: Background: The dangers associated with handling hazardous drugs (HDs) have been well documented. Contamination of the healthcare environment, which can occur during compounding and administration, may lead to drug absorption by...
by CytoPrevent | Apr 6, 2011 | Studies
Cristina Sottani, Benedetta Porro, Marcello Imbriani, Claudio Minoia Abstract: Exposure assessment of health care workers to antineoplastic drugs (ADs) is still an open issue since new, critical, and emerging factors may put pharmacists who prepare hazardous...
by CytoPrevent | Nov 26, 2010 | Studies
Milena Villarini, Luca Dominici, Renza Piccinini, Cristina Fatigoni, Maura Ambrogi, Gianluca Curti, Piero Morucci, Giacomo Muzi, Silvano Monarca, Massimo Moretti Abstract: The International Agency for Research on Cancer has classified several...
by CytoPrevent | Sep 16, 2010 | Studies
Pamela A Ratner, John J Spinelli, Kris Beking, Maria Lorenzi, Yat Chow, Kay Teschke, Nhu D Le, Richard P Gallagher, Helen Dimich-Ward Background: To determine the relationships of potential occupational exposure to antineoplastic drugs with cancer incidence and...
by CytoPrevent | Mar 16, 2010 | Studies
Martha Polovichand, Patricia C. Clark Abstract: Problem: Nurses are potentially exposed to hazardous drugs (HDs) in their practice. HD exposure is associated with adverse outcomes (reproductive problems, learning disabilities in offspring of nurses exposed...